CanSino Biologics(6185 HK): Price Surged - Worth a Shot !!
CanSino Biologics (6185 HK) shares surged on the back of Moderna (MRNA US) breakthroughs with its mRNA vaccine for melanoma. Cansino was China's...
167 Views
HONG KONG ALPHA PORTFOLIO: (September 2026)
HK Alpha portfolio gained 2.22% in September, outperforming its benchmark by 5.36%. Since inception, the portfolio has outperformed HK indexes by...
99 Views
Technically Speaking Breakouts & Breakdowns - HONG KONG (August 2026)
Genscript shares gain after the company announced it will provide wet-lab services to companies participating in Eli Lilly's TundeLab, helping them...
118 Views
HONG KONG ALPHA PORTFOLIO: (August 2026)
HK Alpha portfolio gained 3.45% in August, outperforming its benchmark by 2.67%. Since inception, the portfolio has outperformed HK indexes by 60%...
183 Views
APAC Healthcare Weekly (August 23) – Henlius Bio, Wuxi XDC, Chugai Pharma, Daiichi Sankyo, Celltrion
Henlius strikes biosimilar commercialization deal with Sandoz. Chugai signs exclusive license deal with GSK for anti-dengue virus antibody....
100 Views